Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile Dermatomyositis.

Arthritis Rheumatol · 2020 · PMC7329617 · PMID 32103637

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendP = 0.06so close (0.05 < p ≤ 0.1)

In Cox proportional hazards models, high biomarker levels showed a trend toward conferring a higher risk of “not getting off treatment” as compared to low biomarker levels (for Gal‐9, hazard ratio [HR] 0.32, P = 0.06; for TNFRII, HR 0.24, P = 0.08; for CXCL10, HR 0.39, P = 0.1; for Gal‐1, HR 0.41, P = 0.1).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.